Iris Estrada-García

Iris Estrada-García

Auto-generated profile, based on publicly available information

Iris Estrada-García

Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
VAVioleta D. Alvarez-Jiménez
Violeta D. Alvarez-Jiménez
KLKahiry Leyva-Paredes
Kahiry Leyva-Paredes
MGMariano García-Martínez
Mariano García-Martínez
LVLuis Vázquez-Flores
Luis Vázquez-Flores
VGVíctor Gabriel García-Paredes
Víctor Gabriel García-Paredes
IEIris Estrada-García
Iris Estrada-García
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (Mtb). In the lungs, macrophages and neutrophils are the first immune cells that have contact with the infecting mycobacteria. Neutrophils are phagocytic cells that kill microorganisms through several mechanisms, which include the lytic enzymes and antimicrobial peptides that are found in their lysosomes, and the production of reactive oxygen species. Neutrophils also release extracellular vesicles (EVs) (100–1,000 nm in diameter) to the extracellular milieu; these EVs consist of a lipid bilayer surrounding a hydrophilic core and participate in intercellular communication. We previously demonstrated that human neutrophils infected in vitro with Mtb H37Rv release EVs (EV-TB), but the effect of these EVs on other cells relevant for the control of Mtb infection, such as macrophages, has not been completely analyzed. In this study, we characterized the EVs produced by non-stimulated human neutrophils (EV-NS), and the EVs produced by neutrophils stimulated with an activator (PMA), a peptide derived from bacterial proteins (fMLF) or Mtb, and observed that the four EVs differed in their size. Ligands for toll-like receptor (TLR) 2/6 were detected in EV-TB, and these EVs favored a modest increase in the expression of the co-stimulatory molecules CD80, a higher expression of CD86, and the production of higher amounts of TNF-α and IL-6, and of lower amounts of TGF-β, in autologous human macrophages, compared with the other EVs. EV-TB reduced the amount of intracellular Mtb in macrophages, and increased superoxide anion production in these cells. TLR2/6 ligation and superoxide anion production are known inducers of autophagy; accordingly, we found that EV-TB induced higher expression of the autophagy-related marker LC3-II in macrophages, and the co-localization of LC3-II with Mtb inside infected macrophages. The intracellular mycobacterial load increased when autophagy was inhibited with wortmannin in these cells. In conclusion, our results demonstrate that neutrophils produce different EVs in response to diverse activators, and that EV-TB activate macrophages and promote the clearance of intracellular Mtb through early superoxide anion production and autophagy induction, which is a novel role for neutrophil-derived EVs in the immune response to Mtb.

23 September 2019 in Molecules
Verified
Journal Article
Open access
PDF file
NCNayeli Shantal Castrejón-Jiménez
Nayeli Shantal Castrejón-Jiménez
KLKahiry Leyva-Paredes
Kahiry Leyva-Paredes
SUShantal Lizbeth Baltierra Uribe
Shantal Lizbeth Baltierra Uribe
JCJuan Castillo cruz
Juan Castillo cruz
MCMarcia Campillo-Navarro
Marcia Campillo-Navarro
Blanca Estela García-PérezBlanca Estela García-Pérez
Blanca Estela García-Pérez
Ursolic and oleanolic acids are natural isomeric triterpenes known for their anticancer activity. Here, we investigated the effect of triterpenes on the viability of A549 human lung cancer cells and the role of autophagy in their activity. The induction of autophagy, the mitochondrial changes and signaling pathway stimulated by triterpenes were systematically explored by confocal microscopy and western blotting. Ursolic and oleanolic acids induce autophagy in A549 cells. Ursolic acid activates AKT/mTOR pathways and oleanolic acid triggers a pathway independent on AKT. Both acids promote many mitochondrial changes, suggesting that mitochondria are targets of autophagy in a process known as mitophagy. The PINK1/Parkin axis is a pathway usually associated with mitophagy, however, the mitophagy induced by ursolic or oleanolic acid is just dependent on PINK1. Moreover, both acids induce an ROS production. The blockage of autophagy with wortmannin is responsible for a decrease of mitochondrial membrane potential (Δψ) and cell death. The wortmannin treatment causes an over-increase of p62 and Nrf2 proteins promote a detoxifying effect to rescue cells from the death conducted by ROS. In conclusion, the mitophagy and p62 protein play an important function as a survival mechanism in A549 cells and could be target to therapeutic control.

14 March 2019 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
RSRodolfo Soria-Castro
Rodolfo Soria-Castro
ASAlejandro Schcolnik-Cabrera
Alejandro Schcolnik-Cabrera
GRGloria Rodríguez-López
Gloria Rodríguez-López
MCMarcia Campillo-Navarro
Marcia Campillo-Navarro
NPNahum Puebla-Osorio
Nahum Puebla-Osorio
ABALMA DELIA CHAVEZ BLANCO
ALMA DELIA CHAVEZ BLANCO
Valproic acid (VPA) is widely recognized for its use in the control of epilepsy and other neurological disorders in the past 50 years. Recent evidence has shown the potential of VPA in the control of certain cancers, owed in part to its role in modulating epigenetic changes through the inhibition of histone deacetylases, affecting the expression of genes involved in the cell cycle, differentiation, and apoptosis. The direct impact of VPA in cells of the immune system has only been explored recently. In this review, we discuss the effects of VPA in the suppression of some activation mechanisms in several immune cells that lead to an anti-inflammatory response. As expected, immune cells are not exempt from the effect of VPA, as it also affects the expression of genes of the cell cycle and apoptosis through epigenetic modifications. In addition to inhibiting histone deacetylases, VPA promotes RNA interference, activates histone methyltransferases, or represses the activation of transcription factors. However, during the infectious process, the effectiveness of VPA is subject to the biological nature of the pathogen and the associated immune response; this is because VPA can promote the control or the progression of the infection. Due to its various effects, VPA is a promising alternative for the control of autoimmune diseases and hypersensitivity and needs to be further explored.

2 April 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
LDLuis Donis-Maturano
Luis Donis-Maturano
LUVIA ENID SANCHEZ-TORRESLUVIA ENID SANCHEZ-TORRES
LUVIA ENID SANCHEZ-TORRES
ACArturo Cerbulo-Vázquez
Arturo Cerbulo-Vázquez
RCRommel Chacon-Salinas
Rommel Chacon-Salinas
GGGina S García-Romo
Gina S García-Romo
LFLeopoldo Flores-Romo
Leopoldo Flores-Romo
Neutrophils are one the earliest, crucial innate defenses against innumerable pathogens. Their main microbicidal activities include phagocytosis and degranulation, with many pharmacologically active molecules contributing to inflammation. Recently, a novel antimicrobial mechanism was discovered; the Neutrophil Extracelullar Traps (NETs) formed by extrusion of DNA and associated molecules (histones, elastase, antimicrobial peptides, among others) which trap and kill microorganisms. Since NETs were recently described, research has focused on their induction and microbicidal properties, and recently on disease involvement. However, the functional consequences of NETs interacting with other immune cells, either resident or recruited during early inflammation, have not been assessed. We therefore investigated the consequences of exposing two major APCs, macrophages (Mfs) and conventional Dendritic Cells (cDCs) to NETs. Our data revealed that at early times (30 min), both Antigen Presenting Cells (APCs) showed induction of important costimulatory molecules (CD80, CD86). Unexpectedly, however, at later times (6 and 24 hours) NETs apparently triggered a cell death process in these APCs by a caspase- and Apoptosis induced factor (AIF)-dependent pathway, suggesting mitochondrial damage. By rhodamine-123 labelling we found that in both APCs, relatively prolonged exposure to NETs or their components importantly decreased the mitochondrial membrane potential. Ultrastructural analysis confirmed mitochondrial alterations in both APCs. Our results would suggest that early in inflammation, NETs can activate the two main APCs (Mfs and cDCs), but as the process continues, NETs can then initiate apoptosis of these cells through mitochondrial harm. Conceivable, this “late” induction of cell death in these two APCs might start limiting an ongoing inflammatory process to control it.

17 November 2013 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
MHMaría Eugenia Hernandez
María Eugenia Hernandez
DMDanelia Mendieta
Danelia Mendieta
MPMayra Pérez-Tapia
Mayra Pérez-Tapia
RBRafael Bojalil
Rafael Bojalil
IEIris Estrada-Garcia
Iris Estrada-Garcia
Lenin PavónLenin Pavón
Lenin Pavón
Major depressive disorder (MDD) is a psychiatric illness that presents as a deficit of serotonergic neurotransmission in the central nervous system. MDD patients also experience alterations in cortisol and cytokines levels. Treatment with selective serotonin reuptake inhibitors (SSRIs) is the first-line antidepressant regimen for MDD. The aim of this study was to determine the effect of a combination of SSRIs and an immunomodulator—human dialyzable leukocyte extract (hDLE)—on cortisol and cytokines levels. Patients received SSRIs or SSRIs plus hDLE. The proinflammatory cytokines IL-1β, IL-2, and IFN-γ; anti-inflammatory cytokines IL-13 and IL-10; and 24-h urine cortisol were measured at weeks (W) 0, 5, 20, 36, and 52 of treatment. The reduction in cortisol levels in the SSRI-treated group was 30% until W52, in contrast, the combined treatment induced a 54% decrease at W36. The decline in cortisol in patients who were treated with SSRI plus hDLE correlated with reduction of anti-inflammatory cytokines and increases levels of proinflammatory cytokines at the study conclusion. These results suggest that the immune-stimulating activity of hDLE, in combination with SSRIs, restored the pro- and anti-inflammatory cytokine balance and cortisol levels in depressed patients versus those who were given SSRIs alone.

1 March 2014 in Immunology Letters
Verified
Journal Article
Closed access
JRJuan Ruiz
Juan Ruiz
HVH. Vivanco-Cid
H. Vivanco-Cid
IIIrma Yadira Izaguirre-Hernandez
Irma Yadira Izaguirre-Hernandez
IEI. Estrada-García
I. Estrada-García
LALourdes Andrea Arriaga-Pizano
Lourdes Andrea Arriaga-Pizano
AEA. Escobar-Gutiérrez
A. Escobar-Gutiérrez